Cailin Conner

Articles by Cailin Conner

Cailin ConnerDiabetes | March 22, 2024
The downregulation of PPAR subtype expression in patients with T2D impairs the healing of periodontal tissues.
Read More
Cailin ConnerAsthma | March 21, 2024
A study used machine learning to examine air toxics associated with asthma symptoms.
Cailin ConnerDiabetes | March 12, 2024
A study assessed the long-term efficacy and safety of bariatric surgery compared with medical/lifestyle management.
Cailin ConnerAsthma | March 12, 2024
A study found that cooking on a gas stoves can increase susceptibility to asthma or other respiratory illnesses.
Cailin ConnerDiabetes | December 21, 2023
A study investigated whether SGLT2 inhibitors could protect against diabetic retinopathy in patients with type 2 diabetes.
Cailin ConnerAsthma | December 21, 2023
Body mass index greatly affects the diagnosis and severity of chronic obstructive pulmonary disease and asthma.
Cailin ConnerDiabetes | December 19, 2023
A study described changes in antidiabetic medication use after the start of second-line therapy in patients with T2D.
Cailin ConnerAsthma | December 15, 2023
A study investigated the safety and efficacy of tapering ICS in patients with severe asthma treated with benralizumab.
Cailin ConnerSickle Cell Disease | December 11, 2023
Non-myeloablative versus myeloablative conditioning for HSCT varied in engraftment, hospitalization, and GVHD outcomes.
Cailin ConnerSickle Cell Disease | December 11, 2023
Allotransplantation had "equitable" cost-efficacy in pediatric patients with sickle cell disease in the United States.
Cailin ConnerSickle Cell Disease | December 11, 2023
Recombinant ADAMTS13 treatment exhibited promising safety and efficacy profiles in patients with sickle cell disease.
Cailin ConnerSickle Cell Disease | December 11, 2023
CLIMB SCD-121 data showed exa-cel treatment induced meaningful improvements in health-related quality of life in SCD.
Cailin ConnerSickle Cell Disease | December 11, 2023
Exagamglogene autotemcel met primary and key secondary endpoints in the phase III CLIMB-SCD-121 trial on sickle cell disease.
Cailin ConnerGout | December 12, 2023
A study found notable lipid profile changes in hyperuricemia and early-onset gout.
Cailin ConnerGout | December 9, 2023
Pharmacologic activation of Nrf2 alleviates gout by inhibiting oxidative stress, reducing joint inflammation.
Cailin ConnerGout | December 8, 2023
Metabolic syndrome is strongly linked to hyperuricemia in both genders, especially in women.
Cailin ConnerGout | December 8, 2023
Blood metabolites, particularly hexadecanedioate, are found to have a causal link to a reduced risk of gout.
Cailin ConnerAsthma | December 7, 2023
Asthma symptoms in children may be worsened by parental stress resulting from financial hardship.
Cailin ConnerGout | December 7, 2023
Elevated serum uric acid levels and the presence of gout are associated with an increased risk of colorectal cancer.
Cailin ConnerAsthma | November 30, 2023
Results of a recent survey showed that nearly half of PCPs who completed it were unfamiliar with asthma biologics.